Quality control for digital tomosynthesis in the ECOG-ACRIN EA1151 TMIST trial.

ABSTRACT:

Background

The Tomosynthesis Mammography Imaging Screening Trial (TMIST), EA1151 conducted by the Eastern Cooperative Oncology Group (ECOG)/American College of Radiology Imaging Network (ACRIN) is a randomized clinical trial designed to assess the effectiveness for breast cancer screening of digital breast tomosynthesis (TM) compared to digital mammography (DM). Equipment from multiple vendors is being used in the study.

Purpose

For the findings of the study to be valid and capture the true capacities of the two technology types, it is important that all equipment is operated within appropriate parameters with regard to image quality and dose. A harmonized QC program was established by a core physics team. Since there are over 120 trial sites, a centralized, automated QC pro

SUBMITTER: Maki AK 

PROVIDER: S-EPMC11332660 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature